Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analyzing and validating the prognostic value and immune microenvironment of clear cell renal cell carcinoma
Jingwei Ke, Jie Chen, Xin Liu
Animal Cells and Systems (2022) Vol. 26, Iss. 2, pp. 52-61
Open Access | Times Cited: 11

Showing 11 citing articles:

Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma
Rui Feng, Haolin Li, Tong Meng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
NIPAL4 is an important marker for clear cell renal cell carcinoma prognosis and immunotherapy
Shuyan Wei, Fang Lyu, Bei Qian, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC
Yinghe Ding, Ling Chu, Qingtai Cao, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Integrative exploration of the mutual gene signatures and immune microenvironment between benign prostate hyperplasia and castration-resistant prostate cancer
Fei Wu, Hao Ning, Yang Sun, et al.
The Aging Male (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 6
Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma
Zhiqiang He, Yufan Gu, Huan Yang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 11661-11678
Closed Access | Times Cited: 5
Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma
Yiwei Gu, Hui Zhuo
The Aging Male (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma
Wenbin Tang, Zhiyuan Shi, Yasheng Zhu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma
Kai Wei, Xi Zhang, Dongrong Yang
PeerJ (2023) Vol. 11, pp. e16643-e16643
Open Access | Times Cited: 3
Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing
Junhao Sun, Xinyu Zhang, Fan Wu, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access
MiR-29 and MiR-140 regulate TRAIL-induced drug tolerance in lung cancer
Suyeon Kim, Ki Wook Lee, Yongjin Yoo, et al.
Animal Cells and Systems (2024) Vol. 28, Iss. 1, pp. 184-197
Open Access
Identification of ATP6V0A4 as a potential biomarker in renal cell carcinoma using integrated bioinformatics analysis
Jinming Xu, Jiahao Jiang, Cong Yin, et al.
Oncology Letters (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 1
Page 1

Scroll to top